Zydus and Synthon sign an exclusive development, licensing, supply and commercialization agreement for a novel 505(B)(2) oncology product for the US market…
Groundbreaking CAR T-Cell Therapy: Qartemi® is India’s first global CAR T-cell therapy, locally manufactured at Immuneel’s state-of-the-art facility in Bangalore,…